Surgical approach in patients with T4 bladder cancer as primary treatment: Disaster or option with improved quality of life

Indian Journal of Urology

Volumn 24, Issue 1, 2008, Pages 95-98

  Nagele, Udo ^a   Anastasiadis, Aristotelis G ^a   Merseburger, Axel S ^a   Hennenlotter, Jörg ^a   Horstmann, Markus ^a   Sievert, Karl Dietrich ^a   Stenzl, Arnulf ^a   Kuczyk, Markus A ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Bladder cancer; Cystectomy; Survival; Treatment

Indexed keywords

EID: 38349088906     PISSN: 09701591     EISSN: None     Source Type: Journal    
DOI: 10.4103/0970-1591.38610     Document Type: Article

References (17)

1. Skinner DG, Stein JR Lieskovsky G, Skinner EC, Boyd SD, Figueroa A, et al. 25-year experience in the management of invasive bladder cancer by radical cystectomy. Eur Urol 1998;33:25-6.
2. Figueroa AJ, Stein JP, Dickinson M, Skinner EC, Thangathurai D, Mikhail MS, et al. Radical cystectomy for elderly patients with bladder carcinoma: An updated experience with 404 patients. Cancer 1998;83:141-7.
3. Zebic N, Weinknecht S, Kroepfl D. Radical cystectomy in patients aged > or = 75 years: An updated review of patients treated with curative and palliative intent. BJU Int. 2005;95:1211-4.
4. Rödel C, Grabenbauer GG, Kühn R, Papadopoulos T, Dunst J, Meyer M, et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol. 2002;20:3061-71.
5. Dunst J, Diestelhorst A. Kühn R, Müller AC, Scholz HJ, Formara P. Organ-sparing treatment in muscle-invasive bladder cancer. Strahlenther Onkol 2005;181:632-7.
6. Arias F, Domínguez MA Martìnez E, Illarramendi JJ, Miquelez S, Pascual I, et al. Chemoradiotherapy for muscle invading bladder carcinoma: Final report of a single institutional organ-sparing program. Int J Radiat Oncol Biol Phys 2000;47:373-8.
7. Chen WC, Liaw CC, Chuang CK, Chen MR Chen CS, Lin PY et al. Concurrent cisplatin, 5-fluorouracil, leucovorin and radiotherapy for invasive bladder cancer. Int JRadiat Oncol Biol Phys 2003;56:726-33.
8. Tekin A, Aki FT, Ozen H. Radical cystectomy versus alternative treatments for muscle-confined bladder cancer. Int Urol Nephrol 2001;33: 357-62.
9. Wilson JR Urwin GH, Stower MJ. The role of percutaneous nephrostomy in malignant ureteric obstruction. Ann R Coll Surg Engl 2005;87: 21-4.
10. Lodde M, Palermo S, Comploj E, SignoreUo D, Mian C, Lusuardi L, et al. Four years experience in bladder preserving management for muscle invasive bladder cancer. Eur Urol 2005;47:773-9.
11. George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, et al. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multiinodality therapy. Urology 2004;64:488-93.
12. Douglas RM, Kaufman DS, Zietman AL, Althausen AF, Heney NM, Shipley WU. Conservative surgery, patient selection and cheinoradiation as organ-preserving treatment for muscle-invading bladder cancer. Semin Oncol. 1996;23:614-20.
13. Mantadakis E, Panagiotidis C, Delakas D, Samonis G. Symptomatic relief of patients with advanced bladder carcinoma after regional intra-arterial chemotherapy. Anticancer Res 2003;23:5143-7.
14. Hussain MH, Glass TR, Forman J, Sakr W, Smith DC, Al-Sarraf M, et al. Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases. J Urol 2001;165:56-61.
15. Teramukai S, Nishiyama H, Matsui Y, Ogawa O, Fukushima M. Evaluation for surrogacy of end points by using data from observational studies: Tumor down staging for evaluating neoadjuvant chemotherapy in invasive bladder cancer, Clin Cancer Res 2006;12:139-43.
16. Cam K, Yildirim A, Ozveri H, Turkeri L, Akdas A. The efficacy of neoadjuvant chemotherapy in invasive bladder cancer. Int Urol Nephrol 2002;33:49-52.
17. Nieuwenhuijzen JA Horenblas S, Meinhardt W, van Tinteren H, Moonen LM. Salvage cystectomy after failure of interstitial radiotherapy and external beam radiotherapy for bladder cancer. BJU Int; 2004;94:793-7.